About this event
A one-hour accredited lecture covering the latest evidence on heart failure management, including SGLT2 inhibitors and emerging combination therapies.
Learning objectives
- Review current heart failure guidelines
- Evaluate role of SGLT2 inhibitors
- Discuss patient selection criteria
Speaker
Dr. Jane Roe, MD, FRCPC
University of Toronto
Cardiologist with research focus on heart failure outcomes.
Sponsors
Acme Pharma
Pharmaceutical
Pharmaceutical
Sponsor disclosure
This program is supported by an educational grant from Acme Pharma and Abbott Canada. The sponsor had no role in content selection, speaker selection, or scientific conclusions. Speaker financial disclosures will be presented at the start of the session. This activity is accredited by CFPC.